# Abilis Life Science, Inc. — Form D

Abilis Life Science, Inc. of POTOMAC, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-30. The offering totals $750K, of which $25K was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2017-08-30
- Form: D
- Accession: 0001713661-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $750K
- Amount sold: $25K
- Remaining: $725K
- Investors: 1
- Date of first sale: 2017-07-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-293759

## Issuer

- Name: Abilis Life Science, Inc.
- CIK: 0001713661
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 10613 BOSWELL LANE, POTOMAC, MD, 20854
- Phone: (410) 340-4705

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| BARRY COHEN | Executive Officer | NEW YORK, NY |
| Nikola Kaludov | Executive Officer | Washington, DC |

## More

- [CIK 1713661 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1713661&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001713661-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.